The above data showed that IL-33 played a protective role in the development of gout, we here further explored whether exogenous IL-33-induced amelioration of MSU-induced inflammation correlated with reduction of IL-1β, which is the critical cytokine in the development of MSU-induced inflammation. This evidence concerns the gene IL1B and gout.